Conference Coverage

Neonatal epileptic syndromes are surprisingly common


 

REPORTING FROM IEC 2019

Neonatal and early infantile epileptic syndromes are more common than previously thought, accounting for nearly one in six cases of severe epilepsies of infancy in a comprehensive Australian population-based study, Katherine B. Howell, MD, reported at the International Epilepsy Congress.

“This is an important finding. It’s a considerably larger number than might have been expected and likely has two contributing factors. Neonatal seizures were previously not considered epilepsy, so many previous studies excluded neonates and the conditions were underrecognized. And our large number of ictal EEGs allowed identification of ictal activation, which is a feature of EIMFS [epilepsy of infancy with migrating focal seizures]. Without those ictal recordings, the diagnosis of EIMFS may not have been made,” according to Dr. Howell, a neurologist at the Royal Children’s Hospital and University of Melbourne.

She presented a population-based study of all infants born with severe epilepsies of infancy (SEI) during a 2-year period in the Australian state of Victoria, which is considered an ideal environment for epidemiologic studies because government-funded health care is available to all. SEI was defined as seizures beginning before age 18 months, occurring at a rate of at least one per day for 1 week or weekly for 1 month, refractory to adequate trials of at least two antiepileptic drugs, and accompanied by an epileptiform EEG abnormality. Her focus was on the electroclinical phenotypes of the affected children because of the high clinical utility of this information.

“Assigning an epileptic syndrome is highly useful for clinician-to-clinician communication of an infant’s phenotype. It guides investigation of etiology and possibly selection of optimal therapy, such as steroids in West syndrome. And it can inform prognosis,” Dr. Howell said at the congress sponsored by the International League Against Epilepsy.

She and her coinvestigators analyzed the detailed records of all 114 infants with SEI born during the study period. The incidence was 1 in 2,000 live births.

“Among infants with epilepsy, this patient group with SEI is most critical to better understand. Effective treatment is often not available, the seizure and developmental outcomes are frequently devastating, and the health burden massive,” the neurologist observed.

The full spectrum of SEI

With the help of ictal EEGs, home seizure recordings, MRI scans, and genomic testing, the investigators were able to classify more than 85% of the infants. About 64% had a prototypic syndrome at onset, such as West syndrome, which accounted for 33% of all SEI, or Dravet syndrome, which was diagnosed in 3%.

The prevalence of the prototypic neonatal and early infantile epileptic syndromes was notably higher than previously reported by others: EIMFS accounted for 9% of total SEI, early infantile epileptic encephalopathy (EIEE) for 7%, and early myoclonic encephalopathy (EME) for 2%. This translated to an incidence of 1 in 28,000 live births for EIEE, 1 in 111,000 for EME, and 1 in 22,500 for EIMFS.

“While neither EIEE nor EIMFS are common, these incidences are actually not that much lower than the reported incidence of Dravet syndrome,” the neurologist pointed out.

About 36% of SEI didn’t fit into any of the prototypic syndromes. However, more than half of this subgroup, or 19% of total SEI, were prototypic syndrome like, a designation Dr. Howell and her coworkers used for cases that possessed most but not all of the well-recognized features of a particular prototypic syndrome; for example, West syndrome–like seizures but without hypsarrhythmia. Whether these prototypic syndrome-like SEI have etiologies and outcomes similar to or distinct from the prototypic syndromes remains a topic for further study.

Pages

Recommended Reading

Patients describe significant impact of epilepsy on their lives
Journal of Clinical Outcomes Management
More than one in six patients with status epilepticus are readmitted after hospital discharge
Journal of Clinical Outcomes Management
Insomnia symptoms correlate with seizure frequency
Journal of Clinical Outcomes Management
Cannabis: Doctors tell FDA to get out of the weeds
Journal of Clinical Outcomes Management
Anticholinergic drugs linked to dementia in older populations
Journal of Clinical Outcomes Management
Alzheimer’s disease raises risk for recurrent seizures
Journal of Clinical Outcomes Management
Cutaneous reaction to AEDs? Think autoimmune epilepsy
Journal of Clinical Outcomes Management
Statins crush early seizure risk poststroke
Journal of Clinical Outcomes Management
Antiepileptic drug outcomes have remained flat for 3 decades
Journal of Clinical Outcomes Management
Epilepsy surgery outcome prediction seeks to gain ground
Journal of Clinical Outcomes Management